flumazenil has been researched along with cholecystokinin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, K; Matsuda, I; Matsuoka, Y; Sugaya, K; Terawaki, Y | 1 |
| Kubota, K; Matsuda, I; Sugaya, K | 1 |
| Bradwejn, J; De Montigny, C | 1 |
| Zetler, G | 1 |
| Bonnafous, C; Bueno, L; Martinez, J | 1 |
| Boden, PR; Woodruff, GN | 1 |
| Bell, CJ; Malizia, AL; Nutt, DJ | 1 |
1 review(s) available for flumazenil and cholecystokinin
| Article | Year |
|---|---|
The neurobiology of social phobia.
Topics: Brain; Caffeine; Carbon Dioxide; Cholecystokinin; Epinephrine; Female; Flumazenil; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Lactic Acid; Male; Neurotransmitter Agents; Panic Disorder; Phobic Disorders; Pituitary-Adrenal System; Thyroid Gland; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
6 other study(ies) available for flumazenil and cholecystokinin
| Article | Year |
|---|---|
Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.
Topics: Analgesics; Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlordiazepoxide; Cholecystokinin; Diazepam; Flumazenil; Flurazepam; Male; Mice; Morphine; Naloxone; Pain; Sensory Thresholds; Time Factors | 1985 |
Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Body Temperature; Cholecystokinin; Flumazenil; Injections, Intraperitoneal; Male; Mice; Naloxone; Proglumide; Time Factors | 1985 |
Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Cholecystokinin; Flumazenil; Flurazepam; Hippocampus; Injections, Intravenous; Iontophoresis; Male; Neurons; Pyramidal Tracts; Quinolines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1985 |
Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Blepharoptosis; Body Temperature; Ceruletide; Cholecystokinin; Diazepam; Flumazenil; Harmine; Hypnotics and Sedatives; Male; Mice; Peptide Fragments; Seizures; Sincalide | 1982 |
Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Flumazenil; Gastrointestinal Motility; Gastrointestinal Transit; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1994 |
Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain.
Topics: Animals; Benzodiazepines; Brain Chemistry; Cholecystokinin; Electrophysiology; Flumazenil; Flurazepam; In Vitro Techniques; Neurons; Pentagastrin; Raphe Nuclei; Rats; Receptors, Cholecystokinin; Ventromedial Hypothalamic Nucleus | 1994 |